SMAD6 is required for normal foregut development in humans and frogs
Development · 2026
DOI: 10.1242/dev.205236 ↗At a glance
Journal article in Development, 2026. Written by Vivien Pagan and 8 co-authors. Institution: Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Major MEDLINE topics: Smad6 Protein, Digestive System. 80 references. Funded by: NCI NIH HHS, Allen Foundation, NIDDK NIH HHS.
Abstract (original language)
Esophageal atresia and tracheoesophageal fistula (EA/TEF) are congenital malformations of the foregut. We identified two distinct variants in the BMP/TGFβ repressor SMAD6 in two individuals exhibiting EA/TEF. We investigated the function of SMAD6 in tracheoesophageal development using two orthogonal approaches in Xenopus embryos, both resulting in foregut malformations similar to those observed in EA/TEF. We then used human pluripotent stem cell-derived foregut epithelium and mesenchyme to explore the separate roles of SMAD6 in these germ layers. CRISPR-mediated disruption of human SMAD6 caused an increase in BMP signaling in foregut epithelium and mesenchyme consistent with its role as a BMP repressor. Loss of SMAD6 caused patterning defects in both tissue types; SMAD6−/− endoderm showed increased expression of distal gut tube markers and SMAD6−/− mesenchyme showed increased expression of ventral and posterior markers, including markers of cardiac and liver mesenchyme lineages. Furthermore, SMAD6−/− mesenchyme had decreased ability to form CD31-positive endothelial cells. Our results demonstrate that SMAD6 is required for foregut development and that rare variants in this gene are likely causative for foregut malformations in EA/TEF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Development, Stem Cells, and Regenerative Medicine Graduate Program, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
- Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
ORCID profiles: Wendy K Chung, James M Wells
Funding
- NCI NIH HHS
- Allen Foundation
- NIDDK NIH HHS
- National Institute of Child Health and Human Development
- Shipley Foundation
- NICHD NIH HHS
- L.B. Research and Education Foundation
- National Cancer Institute
Cite
APA
Pagan, V., Rankin, S. A., Edwards, N. A., Thorner, K., Xie, S., Chung, W. K., Shen, Y., Zorn, A. M., & Wells, J. M. (2026). SMAD6 is required for normal foregut development in humans and frogs. Development. https://doi.org/10.1242/dev.205236
Vancouver
Pagan V, Rankin SA, Edwards NA, Thorner K, Xie S, Chung WK, et al. SMAD6 is required for normal foregut development in humans and frogs. Development. 2026. doi:10.1242/dev.205236
BibTeX
@article{Pagan2026,
author = {Pagan, Vivien and Rankin, Scott A and Edwards, Nicole A and Thorner, Konrad and Xie, Shangqian and Chung, Wendy K and Shen, Yufeng and Zorn, Aaron M and Wells, James M},
title = {SMAD6 is required for normal foregut development in humans and frogs},
journal = {Development},
year = {2026},
doi = {10.1242/dev.205236}
}
EUVIMED